State of the Art Management of Patients With Neuromyelitis Optica

To participate in this activity, please:

Join Dr. Michael Levy, neuroimmunologist at Massachusetts General Hospital, for a concise yet comprehensive 45-minute educational session on Neuromyelitis Optica Spectrum Disorder (NMOSD). This antibody-mediated autoimmune condition primarily affects the optic nerve and spinal cord, potentially leading to permanent disability. Dr. Levy's presentation is divided into four informative modules, covering NMOSD pathogenesis, diagnosis criteria, laboratory testing, imaging, and common misdiagnoses. Additionally, he discusses the safety and efficacy of approved and off-label therapy options, offering valuable insights for tailoring treatment plans to suit the unique needs of NMOSD patients.

Course Credit:

0.75 AMA PRA Category 1 CreditsTM

Dates:

Opens: 2023-10-27
Closes: 2024-10-27

Target Audience:

National audience of neurologists and MS specialists, as well as nurse practitioners and physician associates who specialize in neurology.

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

    Presenting Faculty

  • Michael Levy, MD, PhD

    Associate Professor
    Department of Neurology
    Massachusetts General Hospital and Harvard Medical School
    Cambridge, Massachusetts